Bismuth J, Klitfod L, Sillesen H
Department of Vascular Surgery, Gentofte Hospital, University of Copenhagen, Denmark.
Eur J Vasc Endovasc Surg. 2001 Feb;21(2):143-6. doi: 10.1053/ejvs.2000.1293.
to define the level of management of cardiovascular risk factors in patients treated for critical limb ischaemia in a vascular surgical setting.
retrospective review of all (n =147) patients operated on for critical lower extremity ischaemia in 1998. We included pre- and postoperative cardiac events.
only eight (5%) (95% CI; 2-9) were on lipid lowering treatment and 58 (39%) (95% CI; 31-47) using acetylsalicylic acid.
only a minority of patients operated on for CLI were receiving adequate cardiovascular risk factor modification.
确定血管外科环境中接受严重肢体缺血治疗的患者心血管危险因素的管理水平。
回顾性分析1998年所有接受严重下肢缺血手术的患者（n = 147）。我们纳入了术前和术后的心脏事件。
只有8例（5%）（95%可信区间；2 - 9）接受降脂治疗，58例（39%）（95%可信区间；31 - 47）使用阿司匹林。
接受严重肢体缺血手术的患者中只有少数接受了充分的心血管危险因素修正治疗。
